title: Measuring the rate of therapeutic adherence among outpatients with T2DM in Egypt.
abstract: OBJECTIVE
  The promotion of therapeutic adherence is considered as an integral component of pharmaceutical care practice and patient healthcare. It has been shown that despite effective methods of treatment, 50% of diabetic patients fail to achieve satisfactory glycemic control, which leads to accelerated development of complications and increased mortality. Clinical experience indicates that no improvement of metabolic control is possible without patients' adherence to medications. This study sought to examine the rate of medication adherence and different factors affecting it among Type 2 diabetic patients in Egypt.
  
  
  METHODS
  A total of 226 Type 2 diabetic patients who fulfilled the inclusion criteria were recruited in the current study. Adherence to the treatment was evaluated during patients' hospitalization in the Outpatient Clinics of Internal Medicine Department at University of Mansoura, Egypt. The medication adherence has been assessed during a personal interview with each patient using a multiple-choice graded questionnaire.
  
  
  RESULTS
  In the study population, the adherence rates to medication, dietary/exercise and appointment were observed to be suboptimal. The most important social factors that were significantly affecting adherence rate to the prescribed oral hypoglycemic agent(s) included marital status (P < 0.01), family support (P < 0.01), and socio-economical level (P < 0.01). Other patient factors that were significantly affecting therapeutic adherence were patient knowledge about the disease (P < 0.01), patients' beliefs and motivation about prescribed drugs (P < 0.01), and regularity of patients' self monitoring of blood glucose level (P < 0.01). Among drug factors which found to affect significantly the rate of medication adherence are the number of drugs taken (P < 0.05), complexity of drug regimen (P < 0.01), and the presence of drug side effects (P < 0.01). Economical factor played an equally important role. Direct and indirect care costs in relation to patients' income were significantly affecting the rate of adherence to medication (P < 0.01).
  
  
  CONCLUSIONS
  An improvement with the adherence to oral hypoglycemic agent(s) may be achieved through continuing patient education about diabetes, improvement of patients' economical levels as well as a reduction in the cost of medication. Pharmaceutical companies have to be involved and pharmacists have to be payed for helping chronically ill patients to take their medicines correctly for improving clinical outcomes.
authors: Department of Clinical Pharmacy, Pharmacy Practice and Pharmaceutics, Faculty of Pharmacy, University of Mansoura, Mansoura, Egypt ; Department of Pharmacy Practice and Dosage Forms, Oman Pharmacy Institute, Ministry of Health, Muscat, Sultanate of Oman, Oman.
authors: Mohamed E E
authors: ME
authors: Shams
authors: Enaase A M E
authors: EA
authors: Barakat
keywords: Drug compliance; Oral hypoglycemic agents; Pharmaceutical care; T2DM; Therapeutic adherence
references: Clinics (Sao Paulo). 2008 Oct;63(5):573-80
references: 18925314
references: Diabetes Care. 2002 Jun;25(6):1015-21
references: 12032108
references: Saudi Med J. 2009 Dec;30(12):1551-6
references: 19936419
references: Immunol Allergy Clin North Am. 2005 Feb;25(1):107-30
references: 15579367
references: Am J Hypertens. 1988 Jul;1(3 Pt 1):309-12
references: 3291897
references: J Clin Hosp Pharm. 1985 Mar;10(1):107-9
references: 3998182
references: Clin Ther. 2005 Jul;27(7):1064-73
references: 16154485
references: Am J Geriatr Psychiatry. 2005 Dec;13(12):1067-76
references: 16319299
references: Yonsei Med J. 2005 Jun 30;46(3):331-40
references: 15988803
references: Fam Pract. 2004 Apr;21(2):125-30
references: 15020377
references: Value Health. 2008 Jan-Feb;11(1):44-7
references: 18237359
references: Presse Med. 2001 Jun 16-23;30(21):1044-8
references: 11471275
references: Obes Res. 2001 Nov;9 Suppl 4:348S-353S
references: 11707564
references: Diabetes Metab. 2006 Dec;32(6):611-6
references: 17296515
references: J Pharm Pharm Sci. 2004 Nov 12;7(3):350-2
references: 15576016
references: Diabetes Educ. 1990 Jan-Feb;16(1):50-9
references: 2178896
references: Int J Diabetes Dev Ctries. 2008 Jan;28(1):15-8
references: 19902034
references: Clin Ther. 2002 Feb;24(2):302-16
references: 11911560
references: Diabet Med. 2002 Apr;19(4):279-84
references: 11942998
references: Qual Life Res. 2005 Jun;14(5):1311-20
references: 16047506
references: Ther Clin Risk Manag. 2005 Sep;1(3):189-99
references: 18360559
references: Ann Intern Med. 2002 Jul 2;137(1):72-3; author reply 72-3
references: 12093258
references: J Diabetes Sci Technol. 2008 Jan;2(1):127-30
references: 19885187
references: Am J Geriatr Psychiatry. 2005 Feb;13(2):157-65
references: 15703325
references: Pharm Pract (Granada). 2009 Jul;7(3):163-9
references: 25143794
references: Afr Health Sci. 2008 Jun;8(2):67-73
references: 19357753
references: J Med Assoc Thai. 2005 Sep;88 Suppl 4:S149-56
references: 16623020
references: Diabetes Educ. 2007 Nov-Dec;33(6):1014-29; discussion 1030-1
references: 18057270
references: J Health Psychol. 2005 May;10(3):409-23
references: 15857871
references: Diabetes Care. 1993 Aug;16(8):1116-23
references: 8375241
references: Int J Clin Pract. 2008 Feb;62(2):338-51
references: 18199282
references: Patient Educ Couns. 2004 Jul;54(1):55-60
references: 15210260
references: Pharm Pract (Granada). 2010 Jan;8(1):1-17
references: 25152788
references: J Hum Nutr Diet. 2003 Jun;16(3):151-8
references: 12753108
references: Int J Tuberc Lung Dis. 2005 Oct;9(10):1134-9
references: 16229225
references: CMAJ. 2000 May 30;162(11):1553-4
references: 10862223
references: East Mediterr Health J. 1999 Jul;5(4):755-65
references: 11338698
references: Cardiovasc Drugs Ther. 2004 Nov;18(6):475-81
references: 15770435
references: Cochrane Database Syst Rev. 2005 Apr 18;(2):CD003638
references: 15846672
references: Med Care. 1986 Jan;24(1):67-74
references: 3945130
references: Eur Neurol. 2005;54(4):204-11
references: 16401893
references: Prev Med. 2004 Dec;39(6):1249-55
references: 15539064
references: N Engl J Med. 2005 Aug 4;353(5):487-97
references: 16079372